Cargando…

Review of Salvage Therapy for Biochemically Recurrent Prostate Cancer: The Role of Imaging and Rationale for Systemic Salvage Targeted Anti-Prostate-Specific Membrane Antigen Radioimmunotherapy

Despite local therapy with curative intent, approximately 30% of men suffer from biochemical relapse. Though some of these PSA relapses are not life threatening, many men eventually progress to metastatic disease and die of prostate cancer. Local therapy is an option for some men, but many have prog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kosuri, Satyajit, Akhtar, Naveed H., Smith, Michael, Osborne, Joseph R., Tagawa, Scott T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3368159/ https://www.ncbi.nlm.nih.gov/pubmed/22693495 http://dx.doi.org/10.1155/2012/921674

Ejemplares similares

Salvage Brachytherapy for Biochemically Recurrent Prostate Cancer following Primary Brachytherapy
por: Lacy, John M., et al.
Publicado: (2016)

Prostate-Specific Membrane Antigen-Based Therapeutics
por: Akhtar, Naveed H., et al.
Publicado: (2012)

Performance and Impact of Prostate Specific Membrane Antigen-Based Diagnostics in the Management of Men with Biochemical Recurrence of Prostate Cancer and Its Role in Salvage Lymph Node Dissection
por: Krimphove, Marieke J., et al.
Publicado: (2020)

Dose-Escalated Salvage Radiotherapy for Macroscopic Local Recurrence of Prostate Cancer in the Prostate-Specific Membrane Antigen Positron Emission Tomography Era
por: Tamihardja, Jörg, et al.
Publicado: (2022)

Predictive value of Prostate Specific Antigen variations in the last week of salvage radiotherapy for biochemical recurrence of prostate cancer after surgery: A practical approach
por: Vigna‐Taglianti, Riccardo, et al.
Publicado: (2020)

Timing of Early Salvage Therapy for Patients With Biochemical Relapse of Prostate Carcinoma
por: Argalácsová, Soňa, et al.
Publicado: (2023)

The SAFE Pilot Trial—SAlvage Focal Irreversible Electroporation—For Recurrent Localized Prostate Cancer: Rationale and Study Protocol
por: Marra, Giancarlo, et al.
Publicado: (2022)

Interim Prostate-Specific Antigen: Predicting for Biochemical Failure During Salvage Radiation Therapy After Prostatectomy
por: Cardoso, Michael, et al.
Publicado: (2021)

Salvage Cryotherapy for Radiation-Recurrent Prostate Cancer: Outcomes and Complications
por: Finley, David S., et al.
Publicado: (2011)

Evaluation of Serum Calcium as a Predictor of Biochemical Recurrence following Salvage Radiation Therapy for Prostate Cancer
por: Peterson, Jennifer L., et al.
Publicado: (2013)

Salvage radiotherapy for biochemical recurrence after radical prostatectomy: does the outcome depend on the prostate cancer characteristics?
por: Viani, Gustavo Arruda, et al.
Publicado: (2019)

The effects of PSA kinetics on the outcome of hypofractionated salvage radiotherapy for biochemical recurrence of prostate cancer after prostatectomy
por: Ishikawa, Hitoshi, et al.
Publicado: (2020)

PSMA-positive nodal recurrence in prostate cancer: Salvage radiotherapy is superior to salvage lymph node dissection in retrospective analysis
por: Schmidt-Hegemann, Nina-Sophie, et al.
Publicado: (2020)

Study of prostate-specific antigen levels during salvage radiotherapy after prostate cancer surgery
por: Aizawa, Takuya, et al.
Publicado: (2023)

Optimal Definition of Biochemical Recurrence in Patients Who Receive Salvage Radiotherapy Following Radical Prostatectomy for Prostate Cancer
por: Lee, Sung Uk, et al.
Publicado: (2022)

Salvage brachytherapy for local recurrences of prostate cancer treated previously with radiotherapy
por: Gawkowska-Suwinska, Marzena, et al.
Publicado: (2010)

Salvage local therapy for radiation-recurrent prostate cancer – where are we?
por: Zdrojowy, Romuald, et al.
Publicado: (2016)

An Examination of the Association between FOXA1 Staining Level and Biochemical Recurrence following Salvage Radiation Therapy for Recurrent Prostate Cancer
por: Heckman, Michael G., et al.
Publicado: (2016)

Topography of Prostate Cancer Recurrence: A Single-centre Analysis of Salvage Radical Prostatectomy Specimens and Implications for Focal Salvage Treatments
por: Marra, Giancarlo, et al.
Publicado: (2022)

Outcomes and Prediction Models for Exclusive Prostate Bed Salvage Radiotherapy among Patients with Biochemical Recurrence after Radical Prostatectomy
por: Tseng, Chi-Shin, et al.
Publicado: (2021)

Salvage Radiotherapy versus Observation for Biochemical Recurrence following Radical Prostatectomy for Prostate Cancer: A Matched Pair Analysis
por: Tilki, Derya, et al.
Publicado: (2022)

Effect of Salvage Radiotherapy and Endocrine Therapy on Patients with Biochemical Recurrence After Prostate Cancer Operation— a Meta‑Analysis
por: Yuan, Yong, et al.
Publicado: (2021)

Optimal timing of salvage radiotherapy for biochemical recurrence after radical prostatectomy: is ultra-early salvage radiotherapy beneficial?
por: Taguchi, Satoru, et al.
Publicado: (2016)

Extended Salvage Pelvic Lymph Node Dissection in Patients with Recurrent Prostate Cancer
por: Osmonov, Daniar K., et al.
Publicado: (2014)

Salvage brachytherapy for locally recurrent prostate cancer after external beam radiotherapy
por: Yamada, Yasuhiro, et al.
Publicado: (2015)

Salvage Reirradiation Options for Locally Recurrent Prostate Cancer: A Systematic Review
por: Zhong, Jim, et al.
Publicado: (2021)

Mapping of Recurrence Sites Following Adjuvant or Salvage Radiotherapy for Prostate Cancer Patients
por: Gonzalez-Moya, Ana, et al.
Publicado: (2022)

Feasibility and Outcome of PSMA-PET-Based Dose-Escalated Salvage Radiotherapy Versus Conventional Salvage Radiotherapy for Patients With Recurrent Prostate Cancer
por: Vogel, Marco M. E., et al.
Publicado: (2021)

Prostate-Specific Antigen Level at the Time of Salvage Therapy After Radical Prostatectomy for Prostate Cancer and the Risk of Death
por: Tilki, Derya, et al.
Publicado: (2023)

Salvage-Radiation Therapy and Regional Hyperthermia for Biochemically Recurrent Prostate Cancer after Radical Prostatectomy (Results of the Planned Interim Analysis)
por: Beck, Marcus, et al.
Publicado: (2021)

Are all prostate cancer patients "fit" for salvage radiotherapy?
por: González-San Segundo, Carmen, et al.
Publicado: (2020)

Systematic Review of Focal and Salvage Cryotherapy for Prostate Cancer
por: Chin, Yew Fung, et al.
Publicado: (2022)

Target Definition in Salvage Radiotherapy for Recurrent Prostate Cancer: The Role of Advanced Molecular Imaging
por: Amzalag, Gaël, et al.
Publicado: (2016)

Linac-based stereotactic salvage reirradiation for intraprostatic prostate cancer recurrence: toxicity and outcomes
por: Cozzi, Salvatore, et al.
Publicado: (2023)

Bone Marrow Recovery and Subsequent Chemotherapy Following Radiolabeled Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody J591 in Men with Metastatic Castration-Resistant Prostate Cancer
por: Tagawa, Scott T., et al.
Publicado: (2013)

Importance of the site of positive surgical margin in salvage external beam radiation therapy for biochemical recurrence of prostate cancer after radical prostatectomy
por: Kashihara, Tairo, et al.
Publicado: (2018)

High-Intensity Focused Ultrasound as Salvage Therapy for Patients With Recurrent Prostate Cancer After Radiotherapy
por: Song, Wan, et al.
Publicado: (2014)

Salvage Pelvic Lymph Node Dissection in Recurrent Prostate Cancer: Surgical and Early Oncological Outcome
por: Claeys, Tom, et al.
Publicado: (2015)

Salvage brachytherapy in prostate local recurrence after radiation therapy: predicting factors for control and toxicity
por: Henríquez, Iván, et al.
Publicado: (2014)

Salvage CyberKnife-Based Reirradiation of Patients With Recurrent Prostate Cancer: The Single-Center Experience
por: Miszczyk, Leszek, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_i2ck9e2bmh9dd8mtr58u436vnb